DiaSorin LIAISON VZV IgG - HSA Registration DE0507541
Access comprehensive regulatory information for DiaSorin LIAISON VZV IgG in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0507541 and owned by DiaSorin Italia S.p.A.. The device was registered on November 25, 2022.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The LIAISON® VZV IgG assay uses chemiluminescence immunoassay (CLIA) technology for the quantitative determination of specific IgG antibodies to varicella-zoster virus (VZV) in human serum samples. The test has to be performed on the LIAISON® Analyzer family